Ad Code

Responsive Advertisement

Key Manufacturers Operating in Dry Eye Syndrome Market to Hit Lucrative Growth Objectives

 

Market Insights

As per recent research by MarkNtel Advisors, The Global Dry Eye Syndrome Market size is valued at around USD 5.2 billion in 2023 and is projected to grow at a CAGR of around 4.21% during the forecast period, i.e., 2024-30.

Global Dry Eye Syndrome Market Driver:

Growing Number of Eye Care Centers Prompting Surge in Product Utilization – The prevalence of dry eye disease has been increasing worldwide, owing to various reasons such as environmental conditions, hormonal changes, a rise in the geriatric population, autoimmune disorders, etc. This has resulted in a spike in eye clinics & centers globally for treatment. Additionally, the blossoming of eye care centers is majorly driven by the steady boost in professionals, such as ophthalmologists & optometrists. While the number of ophthalmologists is expected to remain stable, the number of optometrists is presumed to raise.

Optometrists offer services through private practices, chain/mass merchandisers, and government organizations. Independent optometrists can differentiate themselves by providing personalized care, building patient loyalty, and offering clinical care. Hence, this allows them to offer a higher level of service to the patients. Thus, the growing number of eye care centers is prompting a surge in product utilization of DED & would propel its demand in the forecast years.

Request Free Sample Report: https://www.marknteladvisors.com/query/request-sample/dry-eye-disease-drugs-market.html

Market Segmentation and Consumer Behavior:

By Product

  • Artificial Tears- Market Size & Forecast 2019-2030, USD Million
  • Anti-inflammatory Drugs- Market Size & Forecast 2019-2030, USD Million
    • Cyclosporine-- Market Size & Forecast 2019-2030, USD Million
    • Corticosteroid-- Market Size & Forecast 2019-2030, USD Million
  • Punctal Plugs- Market Size & Forecast 2019-2030, USD Million
    • Dissolvable-- Market Size & Forecast 2019-2030, USD Million
    • Removable-- Market Size & Forecast 2019-2030, USD Million
  • Others (Secretagogues, Oral drugs, etc.)- Market Size & Forecast 2019-2030, USD Million

By Disease Type

  • Aqueous Dry Eye - Market Size & Forecast 2019-2030, USD Million
  • Evaporative Dry Eye - Market Size & Forecast 2019-2030, USD Million

By Distribution Channel

  • Offline- Market Size & Forecast 2019-2030, USD Million
    • Retail Pharmacies- Market Size & Forecast 2019-2030, USD Million
    • Hospital Pharmacies - Market Size & Forecast 2019-2030, USD Million
  • Online- Market Size & Forecast 2019-2030, USD Million

Read Full Report: https://www.marknteladvisors.com/research-library/dry-eye-disease-drugs-market.html

Dry Eye Syndrome Market Geographical Analysis:

By Region:

  • North America
  • South America
  • Europe
  • Middle East & Africa
  • Asia-Pacific

Key Players and Competitive Strategies in the Dry Eye Syndrome Market

Several prominent players dominate the Dry Eye Syndrome Market, including:

  • Mitotech Pharma
  • ReGen Tree
  • Santen Pharmaceutical
  • HanAll BioPharma
  • Sun Pharma
  • Novaliq
  • Sylentis
  • Alcon
  • Horus Pharma
  • Johnson & Johnson
  • Alderya Therapeutics
  • Visufarma
  • Allergan
  • Prestige Consumer Health
  • Others

Report Delivery - MarkNtel Advisors offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Questions Addressed in this Study

1.What factors are driving the Dry Eye Syndrome Market growth?

2.How is the Dry Eye Syndrome Market expected to grow over the next five years?

3.What are the key insights into the current trends in the Dry Eye Syndrome Market?

4.What is the current size of the Dry Eye Syndrome Market, and how is it projected to change in the future?

6.What is the future outlook for the Dry Eye Syndrome Market in terms of technological advancements and market expansion?

Request Customization - https://www.marknteladvisors.com/query/request-customization/dry-eye-disease-drugs-market.html

Read More:

Why MarkNtel Advisors?

MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

For Media Inquiries, Please Contact:

Call: +1 628 895 8081 | +91 120 4278433

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Post a Comment

0 Comments